Latka logo
OrsoBio logo

OrsoBiorevenue

Palo Alto, CaliforniaFounded 2021CEO Viktor Gauk

OrsoBio is a clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders including obesity, diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis.

orsobio.comLinkedInUpdated Sep 10, 2026
Annual revenue
$2.2M
Sep 2025EST
Employees
18
Sep 2025

OrsoBio revenue

OrsoBio has not published its revenue. Growjo puts it at about $2.2M a year (September 2025).

$0
$1M
$2M
$0
–
$2.2M
20212022–242025
ReportedEstimateFounded 2021 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$2.2MESTGrowjo estimate

OrsoBio CEO & employees

Viktor Gauk is CEO of OrsoBio. OrsoBio has 18 employees (September 2025, LinkedIn).

0
5
10
15
18
2025
ReportedOne figure per year; a reported figure wins over an estimate

OrsoBio FAQ

What is OrsoBio's revenue?

Growjo estimates OrsoBio's revenue at about $2.2M a year (September 2025). The company hasn't published its own figure.

How many employees does OrsoBio have?

OrsoBio has 18 employees as of September 2025, according to LinkedIn.

Who is the CEO of OrsoBio?

Viktor Gauk is the CEO of OrsoBio.

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun OrsoBio? Join the podcast